Analytical Data
-
Gene name
HEPACAM2
-
简介
The HEPACAM2 gene encodes a protein associated with an immunoglobulin superfamily that plays a role in mitosis. Knocking down this gene can lead to prophase cell arrest, abnormal nuclear morphology and apoptosis. HEPACAM2 can be used as a biomarker for the prognosis of colorectal adenocarcinoma. HEPACAM2 Protein, Rat (HEK293, Fc) is the recombinant rat-derived HEPACAM2 protein, expressed by HEK293 , with C-hFc labeled tag.
- Application
-
Alternative Names
HEPACAM family member 2; Mitotic kinetics regulator; MIKI
-
Species
Rat
-
Source
HEK293
-
Tag
C-hFc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
B5DEN8
-
Expression Region
L33-L350
-
Protein Length
Partial
-
Molecular Weight
66-73 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HEPACAM2, also known as Hepatocyte and kidney-specific plasma membrane protein 2, is a novel protein that has garnered attention in recent years due to its potential implications in various biological processes and diseases. Initially identified in the context of liver and kidney functions, HEPACAM2 has been linked to cellular adhesion and signaling pathways that play crucial roles in tissue integrity and regeneration. Recent studies suggest that HEPACAM2 may be involved in the development of certain cancers, including hepatocellular carcinoma and renal cell carcinoma, making it a potential biomarker and therapeutic target. The recombinant protein production of HEPACAM2 allows for a more in-depth investigation of its biological functions and interactions at the molecular level. This research is vital for elucidating the role of HEPACAM2 in disease mechanisms and offers prospects for novel diagnostic and treatment strategies. Understanding the structure and function of HEPACAM2 could pave the way for innovative therapeutic approaches in oncology and regenerative medicine, aiming to improve patient outcomes through targeted interventions.
